Synlett 2015; 26(08): 1081-1084
DOI: 10.1055/s-0034-1380410
letter
© Georg Thieme Verlag Stuttgart · New York

Copper-Powder-Catalyzed Synthesis of Pyrimidines from β-Bromo α,β-Unsaturated Ketones and Amidine Hydrochlorides

Yang Jiao
Department of Applied Chemistry, Kyungpook National University, Daegu 702-701, Republic of Korea   Email: [email protected]
,
Son Long Ho
Department of Applied Chemistry, Kyungpook National University, Daegu 702-701, Republic of Korea   Email: [email protected]
,
Chan Sik Cho*
Department of Applied Chemistry, Kyungpook National University, Daegu 702-701, Republic of Korea   Email: [email protected]
› Author Affiliations
Further Information

Publication History

Received: 14 December 2014

Accepted after revision: 29 January 2015

Publication Date:
20 February 2015 (online)


Abstract

β-Bromo α,β-unsaturated ketones are coupled and cyclized with amidine hydrochlorides in the presence of a catalytic amount of copper powder along with a base to give the corresponding pyrimidines in good yields.

 
  • References and Notes

  • 1 Xie F, Zhao H, Zhao L, Lou L, Hu Y. Bioorg. Med. Chem. Lett. 2009; 19: 275
  • 2 Joffe AM, Farley JD, Linden D, Goldsand G. Am J. Med. 1989; 87: 332
  • 3 Xie F, Li S, Bai D, Lou L, Hu Y. J. Comb. Chem. 2007; 9: 12
  • 4 Wang S, Wood G, Meades C, Griffiths G, Midgley C, McNae I, McInnes C, Anderson S, Jackson W, Mezna M, Yuill R, Walkinshaw M, Fisher PM. Bioorg. Med. Chem. Lett. 2004; 14: 4237
  • 5 Atwal KS, O’Neil SV, Ahmad S, Doweyko L, Kirby M, Dorso CR, Chandrasena G, Chen B.-C, Zhao R, Zahler R. Bioorg. Med. Chem. Lett. 2006; 16: 4796
  • 6 Lagoja IM. Chemistry & Biodiversity 2005; 2: 1
  • 7 Undheim K, Benneche T In Comprehensive Heterocyclic Chemistry II . Vol. 6. Katritzky AR, Rees CW, Scriven EF. V. Pergamon Press; Oxford: 1996: 93
  • 8 Truong VL, Morrow M. Tetrahedron Lett. 2010; 51: 758
  • 9 Huang C, Fu Y, Fu H, Jiang Y, Zhao Y. Chem. Commun. 2008; 6333
  • 10 Gogoi J, Gogoi P, Benbaruah P, Boruah RC. Tetrahedron Lett. 2013; 54: 7136
    • 11a Cho CS, Patel DB, Shim SC. Tetrahedron 2005; 61: 9490
    • 11b Cho CS, Shim HS. Tetrahedron Lett. 2006; 47: 3835
    • 11c Cho CS, Patel DB. Tetrahedron 2006; 62: 6388
    • 11d Cho CS, Kim JU, Choi H.-J. J. Organomet. Chem. 2008; 693: 3677
    • 11e Cho CS, Kim HB, Lee SY. J. Organomet. Chem. 2010; 695: 1744
    • 11f Cho CS, Kim HB. J. Organomet. Chem. 2011; 696: 3264
    • 11g Bae YK, Cho CS. Synlett 2013; 24: 1848
    • 11h Ho SL, Cho CS. Synlett 2013; 24: 2705
    • 11i Bae YK, Cho CS. Appl. Organomet. Chem. 2014; 28: 225
    • 12a Arnols Z, Holly A. Collect. Czech. Chem. Commun. 1961; 26: 3059
    • 12b Coates RM, Senter PD, Baker WR. J. Org. Chem. 1982; 47: 3597
    • 13a Brahma S, Ray JK. Tetrahedron 2008; 64: 2883
    • 13b Jana R, Chatterjee I, Samanta S, Ray JK. Org. Lett. 2008; 10: 4795
    • 13c Karthikeyan P, Meena Rani A, Saiganesh R, Balasubramanian KK, Kabilan S. Tetrahedron 2009; 65: 811
    • 13d Samanta S, Jana R, Ray JK. Tetrahedron Lett. 2009; 50: 6751
    • 13e Nandi S, Ray JK. Tetrahedron Lett. 2009; 50: 6993
    • 13f Jana R, Paul S, Biswas A, Ray JK. Tetrahedron Lett. 2010; 51: 273
    • 13g Samanta S, Yasmin N, Kundu D, Ray JK. Tetrahedron Lett. 2010; 51: 4132
    • 13h Yasmin N, Ray JK. Synlett 2010; 924
    • 13i Paul S, Gorai T, Koley A, Ray JK. Tetrahedron Lett. 2011; 52: 4051
  • 14 Cho CS, Kim HB. Catal. Lett. 2010; 140: 116
  • 15 Lee HK, Cho CS. Appl. Organomet. Chem. 2012; 26: 570
  • 16 Yan S, Tang Y, Yu F, Lin J. Helv. Chim. Acta 2011; 94: 487
  • 17 Kappe CO, Dallinger D, Murphree SS. Practical Microwave Synthesis for Organic Chemists . Wiley-VCH; Weinheim: 2009
  • 18 Performing the reaction on a larger scale (6 times) resulted in a slightly decreased yield of 3a (71%).
    • 19a Murai M, Yoshida S, Miki K, Ohe K. Chem. Commun. 2010; 46: 3366
    • 19b Ryan SJ, Candish L, Martínez I, Lupton DW. Aust. J. Chem. 2011; 64: 1148
  • 20 Luo Y, Herndon JW. Organometallics 2005; 24: 3099
  • 21 Pyrimidines 3 – General Procedure To a 5 mL screw-capped vial was added β-bromo α,β-unsaturated ketone 1 (0.5 mmol) and amidine hydrochloride 2 (0.75 mmol), together with copper powder (Shinyo Pure Chemicals Co., 0.05 mmol), K3PO4 (1.5 mmol), and DMF (3 mL). The reaction mixture was stirred at 110 °C for 24 h. The mixture was then cooled to r.t. and filtered through a short column of silica gel (EtOAc) to remove inorganic salts. Removal of the solvent left a crude mixture, which was separated by TLC [silica gel 60 GF254 (Merck), EtOAc–hexane] to give desired products. Except for known 3e 23 and 3l,24 all new products were characterized spectroscopically as shown below. 4-Pentyl-2-phenyl-5,6,7,8-tetrahydroquinazoline (3a) Oil; yield 107 mg (76%). 1H NMR (400 MHz, CDCl3): δ = 0.93 (t, J = 7.1 Hz, 3 H), 1.34–1.45 (m, 4 H), 1.76–1.91 (m, 6 H), 2.69–2.74 (m, 4 H), 2.90–2.93 (m, 2 H), 7.39–7.47 (m, 3 H), 8.38–8.41 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 14.28, 22.51, 22.80, 22.86, 24.71, 27.51, 32.06, 32.91, 34.34, 128.08, 128.54, 129.89, 138.77, 161.19, 165.16, 168.71. HRMS (EI): m/z [M+] calcd for C19H24N2: 280.1939; found: 280.1941. 2-Methyl-4-pentyl-5,6,7,8-tetrahydroquinazoline (3b) Oil; yield 75 mg (69%). 1H NMR (400 MHz, CDCl3): δ = 0.89–0.92 (m, 3 H), 1.33–1.41 (m, 4 H), 1.61–1.68 (m, 2 H), 1.80–1.88 (m, 4 H), 2.60–2.68 (m, 4 H), 2.62 (s, 3 H), 2.80–2.83 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 14.14, 22.37, 22.67, 22.75, 24.41, 25.81, 28.21, 32.14, 32.53, 34.58, 124.23, 164.08, 164.96, 168.75. HRMS (EI): m/z [M+] calcd for C14H22N2: 218.1783; found: 218.1782. 4-Isopropyl-2-phenyl-5,6,7,8-tetrahydroquinazoline (3c) Solid; yield 86 mg (68%); mp 82–83 °C. 1H NMR (400 MHz, CDCl3): δ = 1.30 (d, J = 6.5 Hz, 6 H), 1.83–1.89 (m, 4 H), 2.72–2.74 (m, 2 H), 2.90–2.92 (m, 2 H), 3.19 (sept, J = 6.5 Hz, 1 H), 7.38–7.46 (m, 3 H), 8.44–8.46 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 21.32, 22.42, 22.90, 24.32, 30.71, 33.02, 124.47, 128.07, 128.44, 129.86, 138.88, 161.13, 165.27, 172.71. HRMS (EI): m/z [M+] calcd for C17H20N2: 252.1626; found: 252.1624. 4-Isopropyl-2-methyl-5,6,7,8-tetrahydroquinazoline (3d) Oil; yield 53 mg (56%). 1H NMR (400 MHz, CDCl3): δ = 1.22 (d, J = 6.5 Hz, 6 H), 1.82–1.85 (m, 4 H), 2.62 (s, 3 H), 2.67–2.69 (m, 2 H), 2.80–2.82 (m, 2 H), 3.14 (quint, J = 6.5 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 21.21, 22.38, 22.92, 24.17, 26.02, 30.43, 32.75, 123.23, 164.39, 164.83, 172.89. HRMS (EI): m/z [M+] calcd for C12H18N2: 190.1470; found: 190.1467. 2-Methyl-4-phenyl-5,6,7,8-tetrahydroquinazoline (3f) Oil; yield 53 mg (47%). 1H NMR (400 MHz, CDCl3): δ = 1.71–1.76 (m, 2 H), 1.89–1.94 (m, 2 H), 2.67–2.69 (m, 2 H), 2.71 (s, 3 H), 2.91–2.94 (m, 2 H), 7.40–7.46 (m, 3 H), 7.50–7.52 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 22.51, 22.93, 25.91, 26.66, 32.58, 124.43, 128.43, 128.75, 129.00, 138.53, 164.57, 165.48, 166.46. HRMS (EI): m/z [M+] calcd for C15H16N2: 224.1313; found: 224.1311. 2,6-Dimethyl-4-pentyl-5,6,7,8-tetrahydroquinazoline (3g) Oil; yield 66 mg (57%). 1H NMR (400 MHz, CDCl3): δ = 0.91 (t, J = 7.1 Hz, 3 H), 1.12 (d, J = 6.6 Hz, 3 H), 1.31–1.50 (m, 5 H), 1.61–1.69 (m, 2 H), 1.82–1.97 (m, 2 H), 2.17–2.25 (m, 1 H), 2.61–2.66 (m, 2 H), 2.62 (s, 3 H), 2.76–2.89 (m, 3 H). 13C NMR (100 MHz, CDCl3): δ = 14.11, 21.86, 22.64, 25.76, 28.18, 28.97, 30.42, 32.09, 32.22, 32.88, 34.55, 123.80, 164.07, 164.69, 168.64. HRMS (EI): m/z [M+] calcd for C15H24N2: 232.1939; found: 232.1941. 2-Methyl-4-pentyl-6,7-dihydro-5H-cyclopenta[d]pyrimidine (3h) Oil; yield 72 mg (70%). 1H NMR (400 MHz, CDCl3): δ = 0.90 (t, J = 7.0 Hz, 3 H), 1.33–1.37 (m, 4 H), 1.66–1.69 (m, 2 H), 2.08–2.14 (m, 2 H), 2.64 (t, J = 8.0 Hz, 2 H), 2.67 (s, 3 H), 2.89 (t, J = 7.5 Hz, 2 H), 2.96 (t, J = 8.0 Hz, 2 H). 13C NMR (100 MHz, CDCl3): δ = 14.14, 22.12, 22.67, 25.91, 28.17, 28.26, 31.96, 34.31, 35.86, 129.26, 165.52, 166.07, 174.25. Anal. Calcd for C13H20N2: C, 76.42; H, 9.87; N, 13.71. Found: C, 76.28; H, 9.80; N, 13.75. 2-Methyl-4-pentyl-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidine (3i) Oil; yield 78 mg (67%). 1H NMR (400 MHz, CDCl3): δ = 0.90 (t, J = 7.0 Hz, 3 H), 1.31–1.42 (m, 4 H), 1.57–1.71 (m, 6 H), 1.84–1.90 (m, 2 H), 2.62 (s, 3 H), 2.72–2.79 (m, 4 H), 2.92–2.95 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 14.12, 22.65, 25.79, 26.00, 27.43, 27.77, 29.42, 32.05, 32.34, 35.72, 38.78, 129.66, 164.08, 166.87, 171.16. HRMS (EI): m/z [M+] calcd for C15H24N2: 232.1939; found: 232.1940. 2-Methyl-4-pentyl-5,6,7,8,9,10-hexahydrocycloocta[d]pyrimidine (3j) Oil; yield 74 mg (60%). 1H NMR (400 MHz, CDCl3): δ = 0.91 (t, J = 7.1 Hz, 3 H), 1.33–1.47 (m, 8 H), 1.63–1.73 (m, 4 H), 1.76–1.82 (m, 2 H), 2.64 (s, 3 H), 2.68–2.72 (m, 2 H), 2.78–2.81 (m, 2 H), 2.86–2.89 (m, 2 H). 13C NMR (100 MHz, CDCl3): δ = 14.18, 22.73, 25.53, 25.91, 25.94, 26.47, 29.54, 30.39, 30.50, 32.23, 34.90, 35.10, 127.16, 164.74, 167.83, 169.37. HRMS (EI): m/z [M+] calcd for C16H26N2: 246.2096; found: 246.2095. 2-Methyl-4-pentyl-5,6,7,8,9,10,11,12,13,14-decahydrocyclododeca[d]pyrimidine (3k) Oil; yield 91 mg (60%). 1H NMR (400 MHz, CDCl3): δ = 0.91 (m, J = 7.1 Hz, 3 H), 1.31–1.72 (m, 20 H), 1.81–1.88 (m, 2 H), 2.62 (s, 3 H), 2.66–2.76 (m, 6 H). 13C NMR (100 MHz, CDCl3): δ = 14.18, 22.48, 22.75, 23.12, 25.21, 25.88, 26.04, 26.57, 26.90, 27.42, 27.83, 28.57, 29.62, 32.23, 32.26, 35.01, 127.49, 164.22, 168.80, 169.20. HRMS (EI): m/z [M+] calcd for C20H34N2: 302.2722; found: 302.2719. 2-Methyl-4-pentyl-5,6-diphenylpyrimidine (3m) Solid; yield 55 mg (35%); mp 62–64 °C. 1H NMR (400 MHz, CDCl3): δ = 0.70–0.74 (m, 3 H), 1.09–1.14 (m, 4 H), 1.49–1.57 (m, 2 H), 2.51–2.55 (m, 2 H), 2.74 (s, 3 H), 7.00–7.02 (m, 2 H), 7.08–7.14 (m, 3 H), 7.19–7.24 (m, 5 H). 13C NMR (100 MHz, CDCl3): δ = 14.07, 22.45, 26.36, 29.25, 31.93, 35.71, 127.62, 127.97, 128.53, 128.63, 129.37, 129.78, 130.48, 136.74, 138.76, 164.17, 166.47, 169.65. HRMS (EI): m/z [M+] calcd for C22H24N2: 316.1939; found: 316.1938.
  • 22 A reviewer suggested that the present reaction might be tolerant of several functional groups such as hydroxy, amino, and ester. However, it is difficult to examine such functional-group compatibility at present since the synthetic course of the starting 1 uses Grignard reagents as a step. Thus, further application of this method to the synthesis of such functional-group-containing pyrimidines needs more elaborate plans.
  • 23 Herrera A, Martínez-Álvarez R, Chioua M, Sánchez Á, Molero D, Chioua R. Magn. Reson. Chem. 2002; 40: 293
  • 24 Herrera A, Martínez-Álvarez R, Chioua M, Chioua R, Sánchez Á. Tetrahedron 2002; 58: 10053